Macrophagic Activation and Immunophenotypic Profile of Patients With Gaucher's Disease
NCT01206673 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2011-12-02
Summary
The aim of this study is to evaluate macrophaging activity and immunologic profile of patients with Gaucher 's disease. For this, one blood sampling will be performed.
Conditions
- Patients With Gaucher's Disease
Interventions
- OTHER
-
Blood sampling
One blood sampling is required for the research
Sponsors & Collaborators
-
Nantes University Hospital
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-12-31
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
Countries
- France
Study Locations
More Related Trials
-
Safety and Efficacy Study of NGGT002 in cPKU Adult Subjects
NCT06687733 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease
NCT00351156 ·Status: COMPLETED
-
Identification of Undiagnosed Gaucher Disease
NCT01716741 ·Status: UNKNOWN ·Phase: NA
-
A Long-Term Follow-up Study of Subjects With Gaucher Disease Who Previously Received AVR-RD-02
NCT04836377 ·Status: TERMINATED
-
SRT in Comparison to ERT on Immune Aspects and Bone Involvement in Gaucher Disease
NCT02605603 ·Status: UNKNOWN
-
Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease
NCT02416661 ·Status: COMPLETED
-
Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease
NCT00004293 ·Status: UNKNOWN ·Phase: PHASE2
-
Respiratory Cathepsins, Proteases Inhibitors and Glycosaminoglycans (GAG) in Mucopolysaccharidosis
NCT04112602 ·Status: COMPLETED
-
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943 ·Status: RECRUITING
-
A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease
NCT01411228 ·Status: COMPLETED ·Phase: PHASE3
-
An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression
NCT06079567 ·Status: RECRUITING ·Phase: NA
-
Biomarkers Related to Bone in Pediatric Gaucher Disease
NCT06116071 ·Status: RECRUITING
-
An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease
NCT06272149 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)
NCT07157254 ·Status: RECRUITING ·Phase: PHASE2
-
Molecular Signatures of Esophageal Atresia
NCT06073158 ·Status: COMPLETED ·Phase: NA
-
PREPL in Health and Disease
NCT02263781 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Gene Therapy Study in Patients With Gaucher Disease Type 1
NCT05324943 ·Status: COMPLETED ·Phase: PHASE1
-
Gaucher Disease Outcome Survey (GOS)
NCT03291223 ·Status: RECRUITING
-
Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3
NCT03485677 ·Status: COMPLETED ·Phase: PHASE3
-
Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic Disorders
NCT03855631 ·Status: COMPLETED
-
Efficacy and Safety of Eliglustat in Chinese Pediatric Patients With Gaucher Disease Type 1 and Type 3
NCT06523517 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment
NCT07277361 ·Status: RECRUITING
-
A Gaucher Disease Gene Therapy Trial With FLT201
NCT07223944 ·Status: RECRUITING ·Phase: PHASE3
-
COL4A1 Gene Related Cerebra-retinal Angiopathy
NCT01097564 ·Status: COMPLETED
-
A Clinical Study for the Treatment of Pediatric and Adolescent Patients With Type 1 Gaucher Disease
NCT06528080 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1